您的位置：首页 > 产品中心 > 183322-18-1， CP-335963
CP-335963
产品价格查看更多规格...
| 产品编号 | 包装单位 | 单价(元) | 国内现货 | 国外库存 | 询价单 |
| 3072660 | 5 MG | 1310 | 2-5天 | 4-6周 | |
| 3072660 | 25 MG | 4770 | 2-5天 | 4-6周 |
产品别名
183322-18-1
CP-335963
PF-508367
4-Chloro-6,7-bis(2-methoxyethoxy)-quinazoline
结构式
基本信息
| Empirical Formula【经验(实验)分子式】 | C14H17ClN2O4 |
| Molecular weight | 312.75 |
| MDL number | MFCD09751265 |
| PubChem Substance ID【PubChem化学物质编号】 | 329823700 |
| NACRES | NA.77 |
| Biochem/physiol Actions【生化/生理作用】 | CP-335963 is an aurora 2 kinase inhibitor, PDGF inhibitor, and anti-proliferative. |
| Other Notes【其他说明】 | This compound was developed by Pfizer for Kinase Phosphatase Biology research. To learn more about Sigma′s partnership with Pfizer and view other authentic, high-quality Pfizer compounds, visit sigma.com/bsm-pfizer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here. |
| Legal Information【法律信息】 | Sold for research purposes under agreement from Pfizer, Inc. Pfizer is a registered trademark of Pfizer, Inc. |
产品性质
| Quality Level【质量水平】 | 100 |
| Assay【测定】 | ≥98% (HPLC) |
| form【形式】 | powder |
| manufacturer/tradename | Pfizer® |
| color【颜色】 | white to off-white |
| solubility【溶解性】 | DMSO: ≥20 mg/mL |
| originator【创始人】 | Pfizer |
| storage temp.【储存温度】 | room temp |
| SMILES string | COCCOc1cc2ncnc(Cl)c2cc1OCCOC |
| InChI | 1S/C14H17ClN2O4/c1-18-3-5-20-12-7-10-11(16-9-17-14(10)15)8-13(12)21-6-4-19-2/h7-9H,3-6H2,1-2H3 |
| InChI key | ZPJLDMNVDPGZIU-UHFFFAOYSA-N |
| packaging【包装】 | 5, 25 mg in glass bottle |
安全信息
| Pictograms【象形图】 | GHS05,GHS07 |
| Signal word【警示用语：】 | Danger |
| Hazard Statements | H302 - H318 |
| Precautionary Statements | P280 - P305 + P351 + P338 |
| Hazard Classifications【危险分类】 | Acute Tox. 4 Oral - Eye Dam. 1 |
| Storage Class Code【储存分类代码】 | 11 - Combustible Solids |
| WGK | WGK 3 |
